about
Current status and future perspectives in differentiated thyroid cancerFollicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter dataPrognostic parameters for recurrence of papillary thyroid microcarcinoma.Positive cytology findings and a negative histological diagnosis of papillary thyroid carcinoma in the thyroid: is it a false-positive cytology or a disappearing tumor?Effects of low-dose and high-dose postoperative radioiodine therapy on the clinical outcome in patients with small differentiated thyroid cancer having microscopic extrathyroidal extension.The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells.NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma.Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyrAssociation between BRAF V600E mutation and recurrence of papillary thyroid cancer.Solitary skin metastasis of papillary thyroid carcinomaStandardized Thyroid Cancer Mortality in Korea between 1985 and 2010Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trialExpression of X-linked inhibitor of apoptosis protein in neoplastic thyroid disorderDifferences in physicians' and patients' perception of acute hypothyroid symptoms induced by thyroid hormone withdrawal in thyroid cancer patients: a multicenter survey in Korea.Changes in the pulmonary function test after radioactive iodine treatment in patients with pulmonary metastases of differentiated thyroid cancer.Reference interval for thyrotropin in a ultrasonography screened Korean populationSub-Classification of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma by Pathologic CriteriaPostoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called "follicular neoplasm"Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedemaChanges in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment.Metastasis to the thyroid diagnosed by fine-needle aspiration biopsy.Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer.Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatmentLack of Associations between Body Mass Index and Clinical Outcomes in Patients with Papillary Thyroid Carcinoma.Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.Metformin Is Associated with a Favorable Outcome in Diabetic Patients with Cervical Lymph Node Metastasis of Differentiated Thyroid CancerRadiofrequency versus Ethanol Ablation for Treating Predominantly Cystic Thyroid Nodules: A Randomized Clinical TrialClinicopathological Significance of Minimal Extrathyroid Extension in Solitary Papillary Thyroid Carcinomas.Characteristics of Korean Patients with Antithyroid Drug-Induced Agranulocytosis: A Multicenter Study in KoreaLong-term consequence of elevated thyroglobulin in differentiated thyroid cancer.Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid CarcinomaClinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma: Usefulness of the Ki-67 Index.Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves DiseaseDiminished Quality of Life and Increased Brain Functional Connectivity in Patients with Hypothyroidism After Total Thyroidectomy.Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer.Is routine central neck dissection necessary for the treatment of papillary thyroid microcarcinoma?Comparison of Thyroglobulin Measurements Using Three Different Immunoassay Kits: A BRAMHS Tg-Plus RIA Kit, a BRAMHS hTg Sensitive Kryptor Kit, and a Beckman Coulter ACCESS Immunoassay Kit.Serum vitamin D3 levels are not associated with thyroid cancer prevalence in euthyroid subjects without autoimmune thyroid disease.Association between expression of X-linked inhibitor of apoptosis protein and the clinical outcome in a BRAF V600E-prevalent papillary thyroid cancer population.Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women.
P50
Q27024484-4528DA75-DF55-4244-8E77-152C6DC4562FQ30825440-A4AF43AD-E424-4D74-B605-3C524E0EF409Q33375538-FAAB6BF8-A175-4E08-B6AC-4EE18DFCFAD0Q33597642-D8AA3F94-8656-487C-B6DD-DFAAEA96A673Q33632648-E94D0827-D581-4EE7-B37B-62F7E40ECE46Q33912895-FA3D0757-4239-40EE-B76C-41785F5B591DQ33931406-CB5DFB53-AA34-4DCE-9138-5ACFDF2BD64AQ33990855-DAC085FE-3F29-4AF3-822F-0D5DF2588496Q34716574-1199C654-15E0-4A40-BED2-0D834A768274Q34839185-B5A98237-1699-4A30-9CE2-98DD21229762Q34839278-A7AC520B-6418-4E1E-A587-34BB03B973C9Q35195766-F80083E0-37DA-4E5E-886E-987318FFF9C2Q35211953-60AD8E1C-8643-44AE-9BCF-57E9B000B2B3Q35507298-B0FB348B-A136-41F7-A852-EB14E333AB02Q35553559-96D5527B-EB69-4842-B0D4-03B3E3403A0CQ35626247-4972AA9F-2B8C-44FF-BBC6-D5F0F1FE4390Q35694463-581127A4-807F-4DA2-B1E6-507A8716CDC9Q35937119-1B88FE12-6749-42CE-92F5-B0D1EBED5A2BQ35948552-38499F26-3332-47CB-856B-C0E5880A445EQ35948612-413C2950-319A-4E05-AA88-CFD034B6A8A4Q36019986-28C01E7C-4225-4771-BD8C-0380CA4D89E7Q36060211-86C4562E-5496-4100-9547-B451E633CB7FQ36124278-4134622A-22D0-44FA-ACB2-4F65624EC49EQ36127584-C3F2A2ED-984D-4E85-8846-CBA865BAD29FQ36218249-852D7E46-4485-4D50-AE56-FA2B52D61653Q36261224-C0984BA2-1C1A-4590-BB1D-33531B38ECB2Q36279876-8937CAF7-D88A-4A81-A595-CECCD3B0462CQ36391799-88DB4E12-C67D-4904-8294-ADFECCFAAE0DQ36489118-E69BBE1C-F178-4E82-ACD3-6E821A0EB50FQ36515458-0ED8BEEF-762F-4441-A302-E6BE6D641437Q36716977-E15972F3-62D2-4164-801F-FDBF4C25FBEBQ36992917-5424ED2C-E97B-4588-94F7-53E97BC772F5Q37043636-C8DE1547-624E-4084-A7ED-9ADE5FF844D8Q37081304-7C1E54A8-C4D9-4D53-8BB7-67F03C7ECD43Q37137657-5C9472FB-2646-44C8-BEE6-E9DB12219826Q37165535-504153D9-87C6-427B-9DC3-2E4A70A35E3FQ37316042-C7E5720D-3B86-46E3-9D67-18CB90D408DCQ37559124-B79179D6-15EB-470F-953A-8E97F2D67E78Q37712610-7584D84F-6F95-4D18-85AE-9D103FC7AD46Q37712687-0D0E4243-A9C4-41FE-BACC-C02E44277073
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Young Kee Shong
@ast
Young Kee Shong
@en
Young Kee Shong
@es
Young Kee Shong
@nl
Young Kee Shong
@sl
type
label
Young Kee Shong
@ast
Young Kee Shong
@en
Young Kee Shong
@es
Young Kee Shong
@nl
Young Kee Shong
@sl
prefLabel
Young Kee Shong
@ast
Young Kee Shong
@en
Young Kee Shong
@es
Young Kee Shong
@nl
Young Kee Shong
@sl
P106
P1153
55666419000
P21
P31
P496
0000-0002-7911-9471
P569
2000-01-01T00:00:00Z